EMCURE
Invest with MTF
Invest Now
Invest in Emcure Pharmaceuticals with 3.27X leverage
Performance
- Low
- ₹1,385
- High
- ₹1,465
- 52 Week Low
- ₹889
- 52 Week High
- ₹1,520
- Open Price₹1,444
- Previous Close₹1,427
- Volume253,433
Investment Returns
- Over 1 Month -0.73%
- Over 3 Month + 6.43%
- Over 6 Month + 5.67%
- Over 1 Year -0.68%
Smart Investing Starts Here Start SIP with Emcure Pharmaceuticals for Steady Growth!
Emcure Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 33.7
- PEG Ratio
- 0.8
- Market Cap Cr
- 26,751
- P/B Ratio
- 5.6
- Average True Range
- 42.68
- EPS
- 42.32
- Dividend Yield
- 0.2
- MACD Signal
- 6.48
- RSI
- 53.59
- MFI
- 58.2
Emcure Pharmaceuticals Financials
Emcure Pharmaceuticals Technicals
EMA & SMA
Current Price
₹1,411.10
-15.4
(-1.08%)
- Bearish Moving Average 0
- Bullish Moving Average 16
- 20 Day
- ₹1,397.29
- 50 Day
- ₹1,385.42
- 100 Day
- ₹1,365.39
- 200 Day
- ₹1,345.55
Resistance and Support
1420.37
- R3 1,535.73
- R2 1,500.37
- R1 1,455.73
- S1 1,375.73
- S2 1,340.37
- S3 1,295.73
Emcure Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Emcure Pharmaceuticals F&O
About Emcure Pharmaceuticals
- NSE Symbol
- EMCURE
- BSE Symbol
- 544210
- Managing Director & CEO
- Mr. Satish Ramanlal Mehta
- ISIN
- INE168P01015
Similar Stocks to Emcure Pharmaceuticals
Emcure Pharmaceuticals FAQs
Emcure Pharmaceuticals share price is ₹1,411 As on 26 December, 2025 | 07:19
The Market Cap of Emcure Pharmaceuticals is ₹26750.6 Cr As on 26 December, 2025 | 07:19
The P/E ratio of Emcure Pharmaceuticals is 33.7 As on 26 December, 2025 | 07:19
The PB ratio of Emcure Pharmaceuticals is 5.6 As on 26 December, 2025 | 07:19
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.